SEC Form 4 · accession 0001470831-26-000738
Bicara Therapeutics Inc. · BCAX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeremy Bender
Director
Period of report
Jul 28, 2026
Accepted (ET)
Jul 29, 2026 · 4:18 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002023658
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $26.88 | Jul 28, 2026 | A | 38,950 | A | — | Jul 28, 2036 | Common Stock | 38,950 | 38,950 | D |
Explanation of responses
- F1One-third of the shares underlying this option shall vest and become exercisable on July 28, 2027, with the remainder vesting in twenty-four equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.